Metraipolis › archive › dc_bcaf1bd7b37b

Succinylation in cancer immunotherapy: mechanisms, biomarkers, and therapeutic implications — Europe PMC PMID:42183207

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42183207
DOI
10.3389/fimmu.2026.1794817
License (as archived)
solo-consultazione
Archived
2026-11-02T14:38:53.764Z
SHA-256 of the archived text
f3cd042042a6b2d45f39f56f0d524f93143d4e2f027818c617702dfc54576538
Stable URL of this page
https://metraipolis.com/documento/dc_bcaf1bd7b37b

How to cite

Succinylation in cancer immunotherapy: mechanisms, biomarkers, and therapeutic implications — Europe PMC PMID:42183207 — Europe PMC (en), https://europepmc.org/article/MED/42183207 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bcaf1bd7b37b (Metraipolis archive dc_bcaf1bd7b37b, sha256 f3cd042042a6b2d45f39f56f0d524f93143d4e2f027818c617702dfc54576538)
BibTeX
@misc{dcbcaf1bd7b37b,
  title = {Succinylation in cancer immunotherapy: mechanisms, biomarkers, and therapeutic implications — Europe PMC PMID:42183207},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42183207},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bcaf1bd7b37b; sha256 f3cd042042a6b2d45f39f56f0d524f93143d4e2f027818c617702dfc54576538},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42183207. Agents can read the archived copy with the MCP tool read_document.